| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C0003250> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C2985546> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34555986_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Doggrell Biomedical Communications, Wynnum, Australia.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Doggrell_Sheila_A>
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/14712598.2021.1985458>
?:doi	10.1080/14712598.2021.1985458
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Expert opinion on biological therapy
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34555986>
?:pmid	<https://research.tib.eu/covid-19/entity/34555986>
?:pmid	34555986
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.117
?:rankingScore_hIndex	73
?:title	Do we need bamlanivimab? Is etesevimab a key to treating Covid-19?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34555986>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34555986>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all